Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab.
Toru KadonoSatoru IwasaKengo NagashimaKotoe OshimaShun YamamotoHidekazu HiranoNatsuko OkitaHirokazu ShojiYoshitaka HonmaAtsuo TakashimaKen KatoToshikazu UshijimaNarikazu BokuPublished in: Cancer medicine (2023)
Patients with MP had a longer PFS than those with SP. Lung and liver metastases had a poorer response to an ICI than lymph node metastases.